Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Curis Swings To Q4 Profit

RELATED NEWS
Trade CRIS now with 

Curis, Inc. (CRIS: Quote) reported net income for the fourth quarter of $6.1 million or $0.07 per share, compared to a net loss of $5.6 million or $0.07 per share for the year-ago quarter.

Revenues for the fourth quarter surged ti $14.1 million from $100,000 a year ago. The increase is the result of $14.0 million in license fee revenues recorded during the fourth quarter of 2011 for payments that Curis received from Genentech for the achievement of certain regulatory objectives related to Erivedge.

Analysts polled by Thomson Reuters expected the company to earn $0.06 per share on revenue of $10.16 million for the fourth quarter.

Click here to receive FREE breaking news email alerts for Curis Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Consumer prices in the U.S. unexpectedly showed a modest increase in the month of September, according to a report released by the Labor Department on Wednesday, with higher prices for food and shelter offsetting a continued decline in energy prices. The European Parliament has given its strong support to the new European Commission with 423 votes in favor, 209 against and 67 abstentions. The approval was crucial for the Juncker Commission to start a five-year term on 1 November. Today's vote marks the last step in the process leading up to the new European Commission. The European Cabinet has a representative each from all 28 EU member states After moving notably higher over the past few sessions, stocks may show a lack of direction in early trading on Wednesday. The major index futures are currently pointing to a roughly flat open for the markets, with the Dow futures up by just 5 points.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.